-
Innovation Ranking
NewInnovation Ranking – Aselsan Elektronik Sanayi Ve Ticaret AS
Aselsan Elektronik Sanayi ve Ticaret AS (ASELSAN), part of the Turkish Armed Forces Foundation, manufactures electronic systems for military and commercial applications. The company’s system offerings include military communication systems, space technologies, information technology systems, avionics and navigation systems, naval systems, air, and missile defense systems, security systems, and land and weapon systems. It focuses on research & development, production, testing, engineering, assembling, integration and sales, after-sales support, consultancy, trading activities; and project preparation, engineering, consultancy, training, contracting, regarding various...
-
Innovation Ranking
NewInnovation Ranking – Turkiye Sise ve Cam Fabrikalari AS
Turkiye Sise ve Cam Fabrikalari AS (Sisecam), a subsidiary of Turkiye IS Bankasi AS involves in production and sale of glass and chemicals. The company offers flat glass, coated glass, mirror glass, patterned glass, laminated glass, solar power glass, automotive and encapsulated glass. It also provides chemical products such as soda and chromium chemicals, industrial raw materials, glass fiber, vitamin K3 and sodium metabisulfite. Sisecam produces designed glassware and glass packaging for various industries including pharmaceuticals, food, beverages and cosmetics....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VE-303 in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Liver Cirrhosis Drug Details: VE-303 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Hepatic Encephalopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Hepatic Encephalopathy Drug Details: VE-303 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VES-001 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VES-001 in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VES-001 in Frontotemporal Dementia (FTD) Drug Details: VES-001 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-303 in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-303 in Clostridioides difficile Infections (Clostridium difficile Associated Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-303 in Clostridioides difficile Infections (Clostridium...
-
Sector Analysis
NewEurope Flat Glass Market Summary, Competitive Analysis and Forecast to 2028
Flat Glass in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Flat glass is typically used for windows and other applications, including glass tables and doors. It is also known as plate glass and sheet glass. - The European Flat Glass market recorded...
-
Sector Analysis
NewFlat Glass Market Summary, Competitive Analysis and Forecast to 2028
Global Flat Glass industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Flat glass is typically used for windows and other applications, including glass tables and doors. It is also known as plate glass and sheet glass. - The global Flat Glass market recorded total revenues of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-800 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-800 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-800 in Solid Tumor Drug Details: VE-800 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VE-800 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VE-800 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VE-800 in Gastric Cancer Drug Details: VE-800 is under development for...